v3.26.3
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Public Offering [Member]
At The Market Offering [Member]
Common Stock [Member]
Common Stock [Member]
Public Offering [Member]
Common Stock [Member]
At The Market Offering [Member]
Additional paid in capital [Member]
Additional paid in capital [Member]
Public Offering [Member]
Additional paid in capital [Member]
At The Market Offering [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Balances (Shares) at Dec. 31, 2024       49,549              
Balances at Dec. 31, 2024 $ 259,651     $ 5     $ 1,192,536     $ (741) $ (932,149)
Vesting of restricted stock units, net of tax, shares       652              
Vesting of restricted stock units, net of tax (633)           (633)        
Exercise of stock options, net of tax, shares       61              
Exercise of stock options, net of tax 228           228        
Issuance of common stock under employee stock purchase plan, shares       158              
Issuance of common stock under employee stock purchase plan 1,048           1,048        
Issuance of warrants, net of transaction costs 1,610           1,610        
Exercise of pre-funded warrants       199              
Stock-based compensation expense 26,188           26,188        
Unrealized gain (loss) on available-for-sale securities, net 89                 89  
Net loss (126,729)                   (126,729)
Balances at Sep. 30, 2025 161,452     $ 5     1,220,977     (652) (1,058,878)
Balances (Shares) at Sep. 30, 2025       50,619              
Balances (Shares) at Jun. 30, 2025       50,389              
Balances at Jun. 30, 2025 213,679     $ 5     1,211,361     (750) (996,937)
Vesting of restricted stock units, net of tax, shares       119              
Vesting of restricted stock units, net of tax (123)           (123)        
Issuance of common stock under employee stock purchase plan, shares       111              
Issuance of common stock under employee stock purchase plan 741           741        
Stock-based compensation expense 8,998           8,998        
Unrealized gain (loss) on available-for-sale securities, net 98                 98  
Net loss (61,941)                   (61,941)
Balances at Sep. 30, 2025 161,452     $ 5     1,220,977     (652) (1,058,878)
Balances (Shares) at Sep. 30, 2025       50,619              
Balances (Shares) at Dec. 31, 2025       50,892              
Balances at Dec. 31, 2025 102,733     $ 5     1,229,442     (687) (1,126,027)
Vesting of restricted stock units, net of tax, shares       957              
Vesting of restricted stock units, net of tax (1,055)           (1,055)        
Exercise of stock options, net of tax, shares       99              
Exercise of stock options, net of tax 816           816        
Issuance of common stock under employee stock purchase plan, shares       181              
Issuance of common stock under employee stock purchase plan 1,544           1,544        
Issuance of common stock and pre-funded warrants upon public offering under at-the-market offering program, shares         11,671 2,319          
Issuance of common stock and pre-funded warrants upon public offering under at-the-market offering program   $ 107,777 $ 18,875   $ 2     $ 107,775 $ 18,875    
Stock-based compensation expense 25,790           25,790        
Unrealized gain (loss) on available-for-sale securities, net (358)                 (358)  
Net loss (108,080)                   (108,080)
Balances at Sep. 30, 2026 148,042     $ 7     1,383,187     (1,045) (1,234,107)
Balances (Shares) at Sep. 30, 2026       66,119              
Balances (Shares) at Jun. 30, 2026       54,164              
Balances at Jun. 30, 2026 71,765     $ 5     1,266,004     (875) (1,193,369)
Vesting of restricted stock units, net of tax, shares       120              
Vesting of restricted stock units, net of tax (255)           (255)        
Exercise of stock options, net of tax, shares       76              
Exercise of stock options, net of tax 647           647        
Issuance of common stock under employee stock purchase plan, shares       88              
Issuance of common stock under employee stock purchase plan 896           896        
Issuance of common stock and pre-funded warrants upon public offering under at-the-market offering program, shares         11,671            
Issuance of common stock and pre-funded warrants upon public offering under at-the-market offering program   $ 107,777     $ 2     $ 107,775      
Stock-based compensation expense 8,120           8,120        
Unrealized gain (loss) on available-for-sale securities, net (170)                 (170)  
Net loss (40,738)                   (40,738)
Balances at Sep. 30, 2026 $ 148,042     $ 7     $ 1,383,187     $ (1,045) $ (1,234,107)
Balances (Shares) at Sep. 30, 2026       66,119